Suppr超能文献

S-腺苷-L-甲硫氨酸对体外CYP2E1催化活性的抑制作用。

Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine.

作者信息

Caro Andres A, Cederbaum Arthur I

机构信息

Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, NY 10029, USA.

出版信息

Biochem Pharmacol. 2005 Apr 1;69(7):1081-93. doi: 10.1016/j.bcp.2005.01.007.

Abstract

The objective of this work was to evaluate the possible in vitro interactions of S-adenosyl-l-methionine (SAM) and its metabolites S-(5'-Adenosyl)-l-homocysteine (SAH), 5'-Deoxy-5'-(methylthio)adenosine (MTA) and methionine with cytochrome P450 enzymes, in particular CYP2E1. SAM (but not SAH, MTA or methionine) produced a type II binding spectrum with liver microsomal cytochrome P450 from rats treated with acetone or isoniazid to induce CYP2E1. Binding was less effective for control microsomes. SAM did not alter the carbon monoxide binding spectrum of P450, nor denature P450 to P420, nor inhibit the activity of NADPH-P450 reductase. However, SAM inhibited the catalytic activity of CYP2E1 with typical substrates such as p-nitrophenol, ethanol, and dimethylnitrosamine, with an IC(50) around 1.5-5mM. SAM was a non-competitive inhibitor of CYP2E1 catalytic activity and its inhibitory actions could not be mimicked by methionine, SAH or MTA. However, SAM did not inhibit the oxidation of ethanol to alpha-hydroxyethyl radical, an assay for hydroxyl radical generation. In microsomes engineered to express individual human P450s, SAM produced a type II binding spectrum with CYP2E1-, but not with CYP3A4-expressing microsomes, and SAM was a weaker inhibitor against the metabolism of a specific CYP3A4 substrate than a specific CYP2E1 substrate. SAM also inhibited CYP2E1 catalytic activity in intact HepG2 cells engineered to express CYP2E1. These results suggest that SAM interacts with cytochrome P450s, especially CYP2E1, and inhibits the catalytic activity of CYP2E1 in a reversible and non competitive manner. However, SAM is a weak inhibitor of CYP2E1. Since the K(i) for SAM inhibition of CYP2E1 activity is relatively high, inhibition of CYP2E1 activity is not likely to play a major role in the ability of SAM to protect against the hepatotoxicity produced by toxins requiring metabolic activation by CYP2E1 such as acetaminophen, ethanol, carbon tetrachloride, thioacetamide and carcinogens.

摘要

本研究的目的是评估S-腺苷-L-甲硫氨酸(SAM)及其代谢产物S-(5'-腺苷)-L-高半胱氨酸(SAH)、5'-脱氧-5'-(甲硫基)腺苷(MTA)和甲硫氨酸与细胞色素P450酶,特别是CYP2E1之间可能的体外相互作用。SAM(而非SAH、MTA或甲硫氨酸)与用丙酮或异烟肼处理以诱导CYP2E1的大鼠肝脏微粒体细胞色素P450产生II型结合光谱。对照微粒体的结合效果较差。SAM不会改变P450的一氧化碳结合光谱,不会使P450变性为P420,也不会抑制NADPH-P450还原酶的活性。然而,SAM会抑制CYP2E1对典型底物如对硝基苯酚、乙醇和二甲基亚硝胺的催化活性,IC(50)约为1.5 - 5mM。SAM是CYP2E1催化活性的非竞争性抑制剂,其抑制作用不能被甲硫氨酸、SAH或MTA模拟。然而,SAM不会抑制乙醇氧化为α-羟乙基自由基,这是一种检测羟自由基生成的方法。在工程改造以表达个体人类P450的微粒体中,SAM与表达CYP2E1的微粒体产生II型结合光谱,但与表达CYP3A4的微粒体不产生,并且SAM对特定CYP3A4底物代谢的抑制作用比对特定CYP贰E1底物的抑制作用弱。SAM还抑制工程改造以表达CYP2E1的完整HepG2细胞中CYP2E1的催化活性。这些结果表明,SAM与细胞色素P450相互作用,特别是与CYP2E1相互作用,并以可逆和非竞争性方式抑制CYP2E壹的催化活性。然而,SAM是CYP2E1的弱抑制剂。由于SAM抑制CYP2E1活性的K(i)相对较高,CYP2E1活性的抑制不太可能在SAM预防由需要CYP2E1代谢激活的毒素(如对乙酰氨基酚、乙醇、四氯化碳、硫代乙酰胺和致癌物)产生的肝毒性的能力中起主要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验